← Back to news

Markets

Amazon vs. Microsoft: Which Cloud Computing Giant Is the Better Buy?

Y

Will Palantir Be a $1 Trillion Company by 2035?

Y

Prediction: Alphabet's Stock Will Deliver Monster Performance Over the Next 2 Years

Y

Has There Ever Been a Better Time to Buy an EV?

Y

Where Will Palantir Stock Be in 5 Years?

Y

Think you’re ‘middle class’ in America? Pew research shows there’s a roughly 49% chance you’re actually not

Y

Where Will Lemonade Stock Be in 5 Years?

Y

What To Expect in Markets This Week: Tariff Deadline, Amazon Prime Day, FOMC Minutes

Y

What To Expect From the Magnificent Seven in the Second Half of 2025

Y

Alpha Picks 'Big Beautiful' Weekly Recap

S

SoFi Stock Has Big News. Is Now the Time to Buy?

Y

3 Ultra-High-Yield Dividend Stocks I Don't Plan on Ever Selling

Y

What Are 5 Great Growth Stocks to Buy That Are Down 20% or More?

Y

My 2 Favorite Stocks to Buy Right Now

Y

Arista Networks' Nvidia Problem And The Solution

S

Morgan Stanley Assumes Coverage of Axsome Therapeutics (AXSM) with an Overweight Rating

Y

Morgan Stanley Raises PT on Apellis Pharmaceuticals (APLS) to $26, Keeps a Hold Rating

Y

Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma

Y

William Blair Initiates Coverage of Harrow (HROW) With an Outperform Rating

Y

Corcept Therapeutics (CORT) Announces Pivotal Data from Phase 3 ROSELLA Trial

Y

Leerink Partners Reiterates a Bullish Stance on Travere Therapeutics (TVTX)

Y

Piper Sandler Maintains a Buy Rating on Cytokinetics (CYTK) With a $107 PT

Y

H.C. Wainwright Reiterates a Buy Rating on Beam Therapeutics (BEAM) With an $80 PT

Y

H.C. Wainwright Maintains a Buy on Legend Biotech (LEGN) With a $75 Price Target

Y

Morgan Stanley Lifts PT on CG Oncology (CGON) to $56, Keeps an Overweight Rating

Y

Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31

Y

LifeSci Capital Maintains a Buy on Immunovant (IMVT) With a $50 PT

Y

I've Been Selling AI Stocks In The Name Of Value, But I Kept Tesla

S

POSCO Holdings to Build US Lithium Plant, Supports EV Supply Chain

Y

Summit Therapeutics Reportedly Makes $15B AstraZeneca Licensing Talks for Lung Cancer Drug

Y

Globalstar Begins Major C-3 Satellite System Ground Expansion with First Antenna Installation in Texas

Y

Citius Pharmaceuticals Prepares for Q2 2025 Commercial Launch of FDA-Approved Cancer Drug LYMPHIR

Y

UroGen Pharma Receives FDA Approval for ZUSDURI for Recurrent Bladder Cancer

Y

Prime Medicine Focuses on Genetic Liver Diseases, Partnered Programs After Positive CGD Data

Y

ImmunoPrecise Antibodies’ LENSai Platform Achieves Breakthrough in Epitope Mapping Accuracy

Y

Newegg Kicks Off 11th Annual FantasTech Sale with Expanded Price Protection

Y

Peloton Launches “Repowered” Resale Marketplace for Used Equipment

Y

Patterson-UTI Reports 103 US Drilling Rigs Operating in May 2025

Y

BridgeBio Pharma Raises $300M Through Partial European Royalty Monetization for BEYONTTRA

Y

Omnicom, Achieve Life Sciences Partner for AI-Driven Launch of New Nicotine Dependence Treatment

Y

Nuvalent Announces Positive Pivotal Data for Zidesamtinib in Lung Cancer

Y

Jazz Pharmaceuticals’ Ziihera Receives Conditional European Approval for Advanced Biliary Tract Cancer

Y

BioCryst Pharmaceuticals Sells European ORLADEYO Business for Up to $264M

Y

Shift4 Payments, UATP Partner to Support Travel Payment Solutions

Y

Hims & Hers Expands into Europe with ZAVA Acquisition

Y

Coherent Corp. Unveils New ACE FL Thulium Fiber Laser for Advanced Medical Treatments

Y

HubSpot Expands CRM Expertise Through Partnership with MatrixPoint

Y

Cloudflare Launches AI Crawler Blocking and “Pay Per Crawl” Model

Y

Schlumberger JV OneSubsea Secures Contract for Northern Lights CCS Project Expansion in Norway

Y

Arista Networks Expands AI-Driven Enterprise Solutions With New Offerings, VeloCloud SD-WAN Acquisition

Y